Psoriasis is a common immune-immediated chronic inflammatory disease, affecting negatively on patients’ quality of life and there is no specific method to cure it. Recently, many studies have shown the association between psoriasis and cardiovascular (CV) disease. Dyslipidaemia plays an important role in atherosclerosis and is a primary risk factor for CV disease. Many researches have shown the changes in serum lipid such as increased triglyceride, total cholesterol, LDL-C, VLDL-C, and decreased HDL-C. The association between psoriasis and dyslipidaemia remains controversial. It is the reason why this field needs to be more studied.